Home » Stocks » LSAC

LifeSci Acquisition Corp. (LSAC)

Stock Price: $16.50 USD 0.21 (1.29%)
Updated November 30, 2:49 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 135.38M
Revenue (ttm) n/a
Net Income (ttm) -553,746
Shares Out 8.20M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $16.50
Previous Close $16.29
Change ($) 0.21
Change (%) 1.29%
Day's Open 16.34
Day's Range 16.10 - 16.87
Day's Volume 20,850
52-Week Range 9.35 - 16.87

More Stats

Market Cap 135.38M
Enterprise Value 135.81M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 8.20M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.07
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 51,093
Short Ratio 3.07
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.15
Revenue n/a
Operating Income n/a
Net Income -553,746
Free Cash Flow n/a
Net Cash -437,217
Net Cash / Share -0.05
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -0.32%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-0.17-
Net Income-0.12-
Shares Outstanding8.221.25
Earnings Per Share-0.07-
Operating Cash Flow-0.17-
Free Cash Flow-0.17-
Cash & Equivalents0.680.03
Total Debt1.00-
Net Cash / Debt-0.320.03
Book Value5.000.02
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name LifeSci Acquisition Corp.
Country United States
CEO Andrew Ian McDonald

Stock Information

Ticker Symbol LSAC
Stock Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Unique Identifier NASDAQ: LSAC
IPO Date March 6, 2020


LifeSci Acquisition does not have significant operations. It intends to acquire assets or businesses through a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses in the biopharma, medical technology, digital health, and healthcare services sectors. The company was founded in 2018 and is based in New York, New York.